Anne-Laure S. L.
- Country
- France
- Department
- Service de Nephrologie Rhumatologie Dermatologie Pediatrique
Research Overview
- A Prospective, Open-label, Multicenter, Randomized Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Renal Allograft Recipients Aged 12 to Less Than 18 Years of Age to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
- Real‑World Effectiveness and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Primary Immune Complex MPGN: Multi‑Country Observational Study
- Phase III Single‑Arm Study of Atrasentan (EXV811) in Children 2–<18 Years with Primary IgA Nephropathy: Proteinuria, PK, Safety
Data & Insights
Has run more than one trial at 31 of 89 partner sites.
Specializations
Transplant Medicine
This investigator specializes in kidney transplantation with particular emphasis on managing post-transplant complications. Their research focuses on immunosuppression strategies and prevention of viral infections in transplant recipients.
- EBV-related complications in transplantation
- Immunosuppression management in adolescent recipients
- Belatacept-based therapy protocols
The investigator's work addresses critical challenges in pediatric and adolescent transplant outcomes.
Nephrotic Disorders
The researcher has extensive involvement in treating childhood nephrotic syndrome and investigating novel therapeutic approaches for managing these conditions.
- Steroid-dependent nephrotic syndrome
- Innovative antibody therapies
- Comparative treatment protocols
Their work encompasses both traditional and innovative therapeutic approaches for pediatric kidney disorders.
Rare Kidney Diseases
The investigator specializes in treating rare renal conditions, with particular expertise in primary hyperoxaluria and hemolytic uremic syndrome.
- Novel treatments for hyperoxaluria
- Pediatric renal disorders
- Experimental therapeutic approaches
Their research encompasses emerging treatments for rare genetic and acquired kidney disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.